Advertisement

One of the original biotech stars, Amgen, has reached agreement to acquire Woburn-based BioVex Group Inc. for what could total $1 billion – $425 million in upfront cash and up to $575 million in additional payments based on regulatory and sales milestones.

Amgen, based in Thousand Oaks, Calif., said that the boards of both companies have approved the deal.

SOURCE

Advertisement
Advertisement